Atossa Therapeutics
ATOS
#9937
Rank
ยฃ36.64 M
Marketcap
ยฃ4.25
Share price
-3.45%
Change (1 day)
662.69%
Change (1 year)

Earnings for Atossa Therapeutics (ATOS)

Earnings in 2025 (TTM): -ยฃ22.86 Million

According to Atossa Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -ยฃ18.94 Million, an increase over its 2023 earnings that were of -ยฃ22.35 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Atossa Therapeutics from 2011 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ22.86 Million20.69%
2024 -ยฃ18.94 Million-15.25%
2023 -ยฃ22.35 Million11.62%
2022 -ยฃ20.02 Million30.84%
2021 -ยฃ15.31 Million15.58%
2020 -ยฃ13.24 Million3.41%
2019 -ยฃ12.81 Million51.16%
2018 -ยฃ8.47 Million40.41%
2017 -ยฃ6.04 Million27.54%
2016 -ยฃ4.73 Million-47.49%
2015 -ยฃ9.01 Million-17.25%
2014 -ยฃ10.89 Million35.91%
2013 -ยฃ8.01 Million112.3%
2012 -ยฃ3.78 Million46.53%
2011 -ยฃ2.58 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ24.91 B-111,272.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
ยฃ0.97 B-4,467.13%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
ยฃ0.98 B-4,512.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
ยฃ30.95 M-238.11%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-ยฃ81.1 Million 261.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-ยฃ5.83 Million-74.02%๐Ÿ‡บ๐Ÿ‡ธ USA